Brief: Essex Bio-Technology Sees Decrease In Revenue By Approximately 20% For Year
Jan 10 (Reuters) - Essex Bio-Technology Ltd 1061.HK :
* ESSEX BIO-TECHNOLOGY SEES DECREASE IN REVENUE AND PROFIT
BY
APPROXIMATELY 20% AND 35%, RESPECTIVELY FOR YEAR
* EXPECTED RESULTS DUE TO SURGE OF COVID-19 INFECTED CASES
PARTICULARLY IN SECOND HALF OF 2022
Further company coverage: 1061.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Essex Bio-Technology
See all newsHong Kong's Essex Bio-Technology H1 revenue falls
Brief: Essex Bio-Technology Posts HY Profit Of HK$110.7 MLN
Brief: Essex Bio-Technology Expects 10% Revenue And 30% Profit Decrease For HY
Brief: Shanghai Henlius Biotech Says Phase 3 Study Of HLX04-O For WAMD Meets Primary Endpoint
Brief: Essex Bio-Technology Posts Final Dividend Of HK$0.07 Per Share